BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24419971)

  • 1. The role of imaging in the active surveillance of small renal masses.
    Wagstaff PG; Zondervan PJ; de la Rosette JJ; Laguna MP
    Curr Urol Rep; 2014 Mar; 15(3):386. PubMed ID: 24419971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended Duration of Active Surveillance of Small Renal Masses: A Prospective Cohort Study.
    Whelan EA; Mason RJ; Himmelman JG; Matheson K; Rendon RA
    J Urol; 2019 Jul; 202(1):57-61. PubMed ID: 30932757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [INTERMEDIATE-TERM FOLLOW-UP OF PATIENTS UNDERGOING ACTIVE SURVEILLANCE FOR SMALL RENAL MASS: INDICATIONS FOR SURGICAL INTERVENTION].
    Bahouth Z; Halachmi S; Moskovitz B; Nativ O
    Harefuah; 2016 Jan; 155(1):37-40, 67. PubMed ID: 27012073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry.
    Uzosike AC; Patel HD; Alam R; Schwen ZR; Gupta M; Gorin MA; Johnson MH; Gausepohl H; Riffon MF; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
    J Urol; 2018 Mar; 199(3):641-648. PubMed ID: 28951284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on active surveillance for clinical T1 renal tumors.
    Joice GA; Pierorazio PM; Allaf ME
    Curr Opin Urol; 2016 Sep; 26(5):405-9. PubMed ID: 27262141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging.
    Kashan M; Ghanaat M; Hötker AM; Duzgol C; Sanchez A; DiNatale RG; Blum KA; Becerra MF; Manley BJ; Casuscelli J; Chiok M; Coleman JA; Russo P; Tickoo SK; Akin O; Hakimi AA
    J Urol; 2018 Aug; 200(2):275-282. PubMed ID: 29496470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
    Pierorazio PM; Johnson MH; Ball MW; Gorin MA; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME
    Eur Urol; 2015 Sep; 68(3):408-15. PubMed ID: 25698065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and radiographic characteristics governing the selection of therapy of small renal masses.
    Jackson M; Cusano A; Haddock P; Staff I; Abarzua-Cabezas F; Kesler S; Meraney A; Shichman S
    Can J Urol; 2014 Dec; 21(6):7529-35. PubMed ID: 25483759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision-making in active surveillance in kidney cancer: current trends and future urine and tissue markers.
    Patel SH; Singla N; Pierorazio PM
    World J Urol; 2021 Aug; 39(8):2869-2874. PubMed ID: 34370079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Active Surveillance for Localized Small Renal Masses.
    Mir MC; Capitanio U; Bertolo R; Ouzaid I; Salagierski M; Kriegmair M; Volpe A; Jewett MAS; Kutikov A; Pierorazio PM;
    Eur Urol Oncol; 2018 Aug; 1(3):177-187. PubMed ID: 31102618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting Patients with Small Renal Masses for Active Surveillance.
    Johnson MH; Allaf ME; Pierorazio PM
    Anticancer Agents Med Chem; 2018; 18(7):931-939. PubMed ID: 29141556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of small renal masses.
    Martínez Rodríguez C; Tardáguila de la Fuente G; Villanueva Campos AM
    Radiologia (Engl Ed); 2020; 62(3):167-179. PubMed ID: 31882171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does renal mass biopsy influence multidisciplinary treatment recommendations?
    Lobo JM; Clements MB; Bitner DP; Mikula MD; Noona SW; Sultan MI; Cathro HP; Lambert DL; Schenkman NS; Krupski TL
    Scand J Urol; 2020 Feb; 54(1):27-32. PubMed ID: 31868063
    [No Abstract]   [Full Text] [Related]  

  • 14. [Active surveillance for renal cell carcinoma].
    Doehn C; Witzsch U; Siebels M
    Aktuelle Urol; 2012 Jul; 43(4):243-9. PubMed ID: 22869494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Five-Year Analysis of a Multi-Institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry.
    Laguna MP
    J Urol; 2016 Feb; 195(2):297-8. PubMed ID: 26852966
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of surveillance imaging following treatment of small renal masses.
    Kowalczyk KJ; Harbin AC; Choueiri TK; Hevelone ND; Lipsitz SR; Trinh QD; Tina Shih YC; Hu JC
    J Urol; 2013 Nov; 190(5):1680-5. PubMed ID: 23764074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to the small renal mass: to treat or not to treat.
    Kim SP; Thompson RH
    Urol Clin North Am; 2012 May; 39(2):171-9, vi. PubMed ID: 22487760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations regarding active surveillance for small renal masses.
    Raman JD
    Can J Urol; 2014 Dec; 21(6):7536. PubMed ID: 25483760
    [No Abstract]   [Full Text] [Related]  

  • 19. Small renal masses: toward more rational treatment.
    Thomas AA; Campbell SC
    Cleve Clin J Med; 2011 Aug; 78(8):539-47. PubMed ID: 21807926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explosive growth of a renal tumor during active surveillance.
    Uhlman MA; Pate SC; Brown JA
    Can J Urol; 2013 Apr; 20(2):6739-41. PubMed ID: 23587518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.